P ulmonary hypertension (PH) is a progressive and life-threatening disease resulting in a progressive increase in pulmonary vascular resistance, cardiac failure, and death. 1 PH is characterized by vascular cell proliferation and structural changes in the vessel wall (pulmonary vascular remodeling). 1 The remodeling process includes muscularization of distal and normally nonmuscularized vessels, hypertrophy of the medial (smooth muscle cells) and adventitial layers, intimal proliferation, and deposition of extracellular matrix proteins.
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vascular remodeling can be reversed by re-exposure to normoxia, 7 the factors implicated in reverse remodeling remain elusive. To identify such factors, we screened for potential candidates leading to reverse remodeling by using DNA microarrays. To determine the onset of expression changes among different genes and the time course of regulation, mice exposed to 3 weeks of chronic hypoxia for the full development of PH were re-exposed to normoxic conditions for 1, 3, 7, 14, and 21 days. In this setup, reoxygenation resulted in a full reversal of PH. In addition to other known genes involved in vascular remodeling processes such as elastin, 8 our whole-genome approach revealed s-adenosylmethionine decarboxylase 1 (AMD-1), one of the major rate-limiting enzyme in polyamine synthesis, as one of the most downregulated genes. Here, against the background that other groups reported increased lung polyamine contents in hypoxia [9] [10] [11] and that pharmacological inhibition of ornithine decarboxylase 1 (ODC-1), the second rate-limiting enzyme of polyamine synthesis, attenuated at least partially the symptoms of hypoxic PH, 11 we focused in detail on AMD-1 and its impact on pulmonary vascular remodeling.
Methods
A detailed description of routine methodologies is provided in the online-only Data Supplement.
Experimental Design
Hypoxic pulmonary vascular remodeling was induced by exposure of adult mice (20-22 g; C57BL/6J) obtained from Charles River Laboratories (Sulzfeld, Germany) to chronic hypoxia (10% O 2 ) in a ventilated chamber, as described previously. 12 Briefly, animals were age-matched and randomly distributed to groups exposed to normoxia, chronic hypoxia (21 days), or chronic hypoxia with subsequent re-exposure to normoxia for 1, 3, 7, 14, 21, or 42 days.
ODC-1 +/− and AMD-1 +/− mice were kept for 28 days in a hypoxic chamber. The EGR1 −/− animals were a kind gift from Patrick Charnay. For interventional investigations, C57BL/6J mice were exposed to either normoxia or chronic hypoxia (28 days) and treated daily with either placebo (5% glucose) or 1 mg/kg body weight SAM486a. SAM486a was synthesized as previously described 13 with slight modifications. All protocols were approved by the governmental Animal Ethics Committee (Regierungspraesidium Giessen).
Patient Characteristics and Measurements
Human lung tissue was obtained from 6 donors (3 female, 3 male; median age, 58 years; interquartile age range, 42-69 years) and 6 patients with idiopathic pulmonary arterial hypertension (4 female, 2 male; median age, 29 years; interquartile age range, 26-45 years) undergoing lung transplantation. Lung tissue was snap-frozen directly after explantation for further analysis. The investigations on human tissue were approved by the ethics committee of the Medical Faculty, Justus-Liebig-Universitaet Giessen (Germany).
Hemodynamic Measurements, Echocardiography, and Tissue Preparation
Please refer to the online-only Data Supplement.
Paraffin Embedding, Immunohistochemical Staining, and Microscopy
Laser Microdissection, RNA Isolation, cDNA Synthesis, and Quantitative Polymerase Chain Reaction
For laser-assisted microdissection, RNA isolation, cDNA synthesis, and quantitative polymerase chain reaction, please refer to the online-only Data Supplement.
Isolation of Aorta and Carotid Artery
Microarrays
RNA from 80 animals (20 controls and 12 per time point) was analyzed in a total of 40 dual-color hybridizations in a balanced dye-swap design in which each time point was directly compared with the control and adjacent time points. Stored data were evaluated with R software 14 and the limma package 15 from BioConductor. 16 Gene-set enrichment analyses were done with the "geneSetTest" function, together with the KEGG pathway information given in the Bioconductor database package mgug4122a.db version 2.2.5.
Significantly enriched pathways were selected on the basis of a 5% false-discovery rate. For further details, please refer to the online-only Data Supplement.
Nonisotopic In Situ Hybridization Combined With Immunofluorescence on Mouse Lung Sections
Nonisotopic in situ hybridization was carried out as previously described 17 with slight modifications. For further details, please refer to the online-only Data Supplement.
Cell Culture
Human (h) pulmonary arterial smooth muscle cells (PASMCs) were purchased from Lonza (Cologne, Germany) and grown to near confluence. Murine (m) PASMCs were isolated from precapillary vessels modified from a previously reported protocol. 18, 19 
Proliferation and Apoptosis Assay
Binding Sites
The human AMD-1 gene was screened 5000 bp downstream and upstream from the coding sequence for the presence of early growth response 1 (Egr1) binding sites (cgtccccgc) and hypoxia-inducible transcription factor (HIF) consensus sequences (murine promoter, cacgtggt; human, tacgtggg). The AMD-1 sequences were obtained from http://www.ncbi.nlm.nih.gov/mapview/.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation assay was performed 1.5 hours after epidermal growth factor (EGF) treatment or exposure to hypoxia (2 hours, 1% O 2 ) using the Chromatin Immunoprecipitation Assay Kit (Millipore, Billerica, MA) according to the manufacturer's instructions. Antibodies were used against Egr1 (Cell Signaling, Boston, MA), HIF-1α, and HIF-2α (both Novus Biologicals, Littleton, CO). IgG (Millipore, Schwalbach, Germany) served as negative control.
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Plasmid Construction
Full-length human AMD-1 cDNA (accession number, NM_001634) was cloned into the plXIN vector (Clonetech, Mountain View, CA). For more details, please see the online-only Data Supplement.
Western Blot Analysis
Statistical Analysis
Data from animal experiments and from human tissue were analyzed similarly. Effect sizes are given as mean±95% confidence interval. Data are presented in box plots unless indicated differently. Boxes represent the 25th and 75th percentiles; black bars indicate the median; and whiskers display the 0th and 100th percentiles. P values for pairwise comparisons of groups were calculated from the Student t distribution. They are intended to represent a descriptive summary for the statistical significance of the difference in group means. Accordingly, P values from multiple comparisons were calculated from pooled variance estimates. Comparisons with values of P<0.05 are indicated in the diagrams. When the group sizes were between 6 and 8, symbols are shown only when the P value of the Wilcoxon test was also <0.05. When appropriate, data were analyzed by 2-factor ANOVA. The main research questions-whether AMD-1 mRNA expression was changed during the reversal of PH on reoxygenation or during the time course of exposure to hypoxia and whether AMD-1 +/− mice were protected from hypoxia-induced increase in right ventricular systolic pressure (RVSP)-were tested at a 5% level of significance after Bonferroni correction for multiple testing. The antagonistic effect of the AMD-1 gene knockout on the hypoxiainduced increase in RVSP was tested as an interaction in the 2-factor ANOVA. The compliance of the assumptions (homoscedasticity, normal distribution) was checked with normal quantile-quantile plots and Shapiro-Wilk tests.
Results

Hypoxia-Induced Remodeling Can Be Reversed by Re-Exposure to Normoxia
To investigate the effect of reoxygenation after chronic hypoxic exposure on parameters characterizing PH, mice were randomly distributed to groups exposed to normoxia, chronic hypoxia (21 days, 10% O 2 ), or chronic hypoxia with subsequent reoxygenation for the indicated time spans. Three weeks of chronic hypoxic exposure resulted in the development of PH, proven by an increase in RVSP, right heart hypertrophy, and degree of muscularization of small pulmonary vessels ( Figure 1A--1D ). Re-exposure of chronic hypoxic mice resulted in a reversal of PH ( Figure 1A-1D ). Vascular remodeling was accompanied by increased proliferation, whereas re-exposure to normoxia resulted in decreased proliferation, indicated by the expression of the proliferation markers Ki67 and proliferating cell nuclear antigen ( Figure 1E and 1F). Furthermore, immunostaining identified proliferating cell nuclear antigen-positive cells within the vascular wall. The number of proliferating cells increased during chronic hypoxia but decreased after 14 days of re-exposure to normoxia ( Figure 1G ).
AMD-1 Expression Is Decreased During the Process of Reverse Remodeling
To decipher changes in gene expression during reverse remodeling, whole-genome DNA microarray analysis was performed. The experimental design is depicted in Figure 2A . Our screening confirmed several pathways known to be involved in the pathogenesis of PH such as calcium and mitogen-activated protein kinase signaling, as well as cell cycle and apoptosis factors, which were also identified for the reversal of PH ( Figure 2B ). Additionally, many genes implicated in vascular remodeling, including elastin or collagens, were differentially expressed ( Figure 2C ). Interestingly, one of the most downregulated genes during normoxic re-exposure was AMD-1 ( Figure 2C and 2D) . AMD-1 was consistently downregulated in all investigated time points during reverse remodeling ( Figure 2C and 2E) . Furthermore, AMD-1 was upregulated during exposure of mice to 3 weeks of hypoxia ( Figure 2F ). In contrast to the oxygen-dependent regulation in the lung, AMD-1 levels were mostly unchanged in the systemic vasculature ( Figure IA and IB in the online-only Data Supplement) on hypoxic exposure.
AMD-1 Expression Is Elevated in Intrapulmonary Vessels
To determine the localization of AMD-1 in the mouse lung, we performed nonisotopic in situ hybridization combined with immunofluorescence staining. Higher AMD-1 mRNA signal intensity was detected in mouse lungs exposed to chronic hypoxia compared with normoxic animals. Immunostaining against α-smooth muscle actin (α-sma) localized AMD-1 expression to smooth muscle layers of the bronchi and pulmonary vessels ( Figure 3A ). Laser microdissection of intrapulmonary vessels with quantitative polymerase chain reaction verified the expression and upregulation of AMD-1 in this compartment ( Figure 3B ). Similar to our findings in mice, we observed higher expression of AMD-1 in the vessels from patients with idiopathic pulmonary arterial hypertension compared with donors ( Figure 3C and 3D ). Controls are shown in Figure IIA and IIB in the online-only Data Supplement.
AMD-1 +/− Mice Develop Attenuated HypoxiaInduced PH
To investigate whether AMD-1 is involved in the development of hypoxia-induced PH, AMD-1 +/− mice were exposed to either chronic hypoxia (28 days) or normoxia. No differences in hemodynamic measurements were observed under normoxic conditions between AMD-1 +/− and wild-type (WT) animals ( Figure 4A ). In contrast, AMD-1 +/− mice developed a significantly lower degree of PH determined by RVSP ( Figure 4A ). Furthermore, loss of 1 AMD-1 allele resulted in a decreased ratio of right ventricular to left ventricular plus septal mass and a higher degree of nonmuscularized pulmonary vessels on chronic hypoxic exposure ( Figure 4B and 4C and Figure IIIA in the online-only Data Supplement). Because the vascular remodeling process on chronic hypoxia was accompanied by increased proliferation ( Figure 1E-1G ), we were interested in whether depletion of AMD-1 had an impact on cell proliferation. Western blot analysis of whole-lung homogenate from AMD-1 +/− mice demonstrated diminished proliferating cell nuclear antigen expression compared with WT littermates ( Figure 4D 
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4F). Decreased proliferation was consistent with augmented apoptosis ( Figure 4G ). Consistently, overexpression of AMD-1 led to enhanced Ki67 mRNA expression and proliferation ( Figure 4H and 4I), whereas apoptosis was attenuated ( Figure 4J ). were re-exposed to normoxia for the indicated time periods. B, Perturbed pathways during reverse remodeling assessed by DNA microarray analysis. Gray scale represents P values from the gene-set test ranging from <0.01 (black) to 1.00 (white). Values were derived from animals exposed to hypoxia (21 days, n=20) and mice re-exposed to normoxia (n=12 per time point). CAM indicates cell adhesion molecule; MAPK, mitogen-activated protein kinase; and TGF, transforming growth factor. C, Selected and perturbed genes during reverse remodeling assessed by DNA microarray analysis. Displayed genes in at least 2 time points were differentially regulated by a factor of 1.5 compared with hypoxic controls. Colors represent regulation ranging from downregulated (bright red) to upregulated (bright green). Values were derived from animals exposed to hypoxia for 21 days (n=20) and re-exposure to normoxia (n=12 per time point). D, Volcano plot: statistical significance versus regulation. Genes with log odds values ≥5 were considered to be regulated; black spots show AMD-1 regulation. The 2 different values for AMD-1 expression result from 2 different probes against AMD-1 spotted on the microarray chips used. E, AMD-1 mRNA expression quantified by quantitative polymerase chain reaction (q-PCR) during the reversal of PH. Values were derived from n=5 to 7 animals and normalized to B2M. F, AMD-1 mRNA expression levels during the time course of exposure to hypoxia as analyzed by q-PCR and normalized to B2M (n=5-6 animals). *P<0.05 vs respective controls. 
AMD-1 mRNA Expression Is Stimulated by EGF
To investigate whether hypoxia can upregulate AMD-1 expression by its direct effect on PASMCs, for example, via HIF, mPASMCs and hPASMCs were exposed to hypoxia (1% O 2 ) for 24 hours. Contrary to our expectation, hypoxia had no effect on AMD-1 mRNA levels ( Figure 5A and 5B). Although Figure 3 . S-adenosylmethionine decarboxylase 1 (AMD-1) is localized predominantly in pulmonary smooth muscle cells. A, Fluorescence in situ hybridization (FISH) for AMD-1 (red) combined with immunofluorescence staining for α-smooth muscle actin (SMA; green) of mice exposed to hypoxia for 21 days compared with normoxic controls. Representative images are shown. Scale bars, 20 μm for the lower and 10 μm for the higher magnification. B indicates bronchus; and V, vessel. B, AMD-1 mRNA regulation in laser-microdissected pulmonary vessels from chronic hypoxic mice compared with normoxic controls (n=6 each) and normalized to B2M. C, FISH for AMD-1 (red) combined with immunofluorescence staining for sma (green) of idiopathic pulmonary arterial hypertension (IPAH) or control (donor) tissue. Representative images are given. Scale bars, 50 μm in the lower and 20 μm in the higher magnification. Higher-magnification images for A and B were taken by different microscopic settings. D, AMD-1 mRNA expression in laser-microdissected pulmonary vessels from donor compared with IPAH lungs (n=5). *P<0.05 vs respective controls and normalized to B2M.
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we identified an HIF-responsive element in both the murine and human AMD-1 promoter ( Figure To investigate the mechanisms underlying AMD-1 regulation in PH, hPASMCs were stimulated with growth factors known to be upregulated under hypoxic conditions in, for example, endothelial cells. 20 Whereas there was no effect in response to platelet-derived growth factor-BB (data not shown), transforming growth factor-β1 induced a slight but consistent AMD-1 upregulation. The strongest time-dependent increase in AMD-1 expression was caused by EGF ( Figure 5C and 5D). Interestingly, both transforming growth factor-β1-and EGF-induced AMD-1 upregulation was not observed when hPASMCs were exposed to hypoxia ( Figure VIE 
EGF Regulates AMD-1 Expression via Egr1 Transcription Factor
Because EGF can induce multiple transcription factors, including early growth response (Egr1), 22 we next studied whether EGF can induce Egr1 expression in hPASMCs. Stimulation of hPASMCs with EGF induced Egr1 mRNA and protein levels with the highest median values after 1 hour ( Figure 5E and 5F). An automated computational analysis using a gene prediction method was applied for screening of potential Egr1 consensus sequences within the AMD-1 promoter region. Similar to previous findings, 23 This finding was further confirmed by chromatin immunoprecipitation ( Figure 5H ). With the use of primers flanking the Egr1-binding site in the AMD-1 promoter, a PCR product was detected in the input material and immunoprecipitated chromatin after EGF stimulation ( Figure 5H , lanes 2 and 4). The EGF-induced increase in AMD-1 expression was attenuated by the EGFR inhibitor AG1478 ( Figure 5I ).
EGF Regulates Egr1 Expression via Erk1/2
Because accumulating evidence suggests that EGF can increase Egr1 levels via Erk1/2 signaling, 22 we investigated whether this pathway also controls the Egr1 increase in hPASMCs. Indeed, EGF application induced Erk1/2 phosphorylation ( Figure 6A ), which was attenuated by the Erk1/2 inhibitor U0126 ( Figure 6B ). Additionally, application of U0126 prevented the EGF-dependent increases in Egr1 expression ( Figure 6C and 6D ). To further demonstrate the importance of Egr1 in regulating AMD-1, we examined AMD-1 expression in PASMCs from Egr1 −/− and WT mice in response to EGF stimulation. In contrast to cells from WT mice, AMD-1 mRNA expression was not affected in PASMCs from Egr1 −/− mice ( Figure 6E ). Additionally, EGF stimulation did not enhance the proliferation of PASMCs isolated from Egr1 −/− knockout compared with to WT mice ( Figure 6F ).
AMD-1 Depletion Attenuates Phospholipase Cγ1 Phosphorylation
In the next step, we assessed whether AMD-1 depletion has effects on phospholipase Cγ1 (PLC-γ1) phosphorylation. As depicted in Figure 7A , depletion of AMD-1 resulted in decreased PLC-γ1 phosphorylation. Similar effects were observed in lungs from AMD-1 +/− mice ( Figure 7B ). Furthermore, EGF induced PLC-γ1 phosphorylation in hPASMCs, which was diminished by U0126 and the PLC inhibitor U73122 ( Figure 7C ).
AMD-1 Inhibition Impairs Hypoxia-Induced PH
Finally, we were interested in whether pharmacological inhibition of AMD-1 in vivo was able to inhibit hypoxia-induced PH. Therefore, the selective AMD-1 inhibitor SAM486a was used in WT mice during hypoxic exposure. Although RVSP was not reduced compared with hypoxic placebo controls ( Figure 8A ), right heart hypertrophy was improved considerably by AMD-1 inhibition ( Figure 8B ). In addition, the ratio of pulmonary artery acceleration time to pulmonary artery ejection time determined by echocardiography was ameliorated compared with hypoxic placebo controls ( Figure 8C ). Furthermore, maintained cardiac function was confirmed by the prevention of the hypoxia-induced decline in cardiac index and the avoidance of hypoxia-induced enhancement in 
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right ventricular internal diameter, total pulmonary resistance, and myocardial performance index ( Figure 8D-8G) . In addition, AMD-1 inhibition prevented the increase in the degree of muscularization in small pulmonary arteries because the percentage of fully muscularized vessels was lower than in hypoxic placebo controls ( Figure 8H and 8I).
Discussion
The major findings of our study are that (1) PH induced in mice by chronic hypoxic exposure is fully reversible on re-exposure to normoxia, including a reversal of right heart hypertrophy and vascular remodeling; (2) this model in combination with genome-wide screening can be used to identify factors involved in the reversal of the disease and its development; and (3) AMD-1 is a potential key player for both the progression and the reversal of PH. Furthermore, we deciphered AMD-1 signaling in the pulmonary vasculature by a variety of different approaches, including cellular studies, knockout mice, and in vivo inhibition of AMD-1. On exposure to chronic hypoxia, the pulmonary vasculature undergoes remodeling, resulting in sustained elevation in pulmonary vascular resistance and right heart hypertrophy. It has previously been shown that re-exposure of rats to normoxia reduces vascular changes, which are accompanied by decreased RVSP and lower right heart hypertrophy. 7, 24 Going beyond these data, we have shown in a detailed time kinetic that PH, the accompanying right heart hypertrophy, and the structural vascular alterations underlying hypoxia-induced PH are fully reversible on reoxygenation in mice.
The use of a microarray analysis during the course of PH reversal identified genes and pathways that are regulated during this process and could be key factors for both the reversal and, as shown by our analysis, the development of PH. Of all genes differentially expressed during reverse remodeling, we focused here on further delineating the function of AMD-1 in vascular remodeling for the following reasons: AMD1 was one of the most downregulated genes in our screen; AMD-1 was demonstrated to be involved in embryonic development 25 ; AMD-1 has been reported to be associated with cancer progression 26 ; and AMD-1 has been linked to tissue repair. 26 AMD-1 is one of the major rate-limiting enzymes in polyamine synthesis. The polyamine precursor putrescine is generated by ODC-1; in turn, AMD-1 is required for the conversion of putrescine to polyamines. A large body of evidence suggests that polyamine suppression decreases cell growth, angiogenesis, and the expression of genes affecting tumor invasion and apoptosis. 27, 28 The prominent role of polyamines in directing cell proliferation, an important characteristic of vascular remodeling, revealed a possible involvement of AMD-1 in regulating responses to hypoxia in the pulmonary vasculature. In accordance with this assumption, we could show that hypoxic exposure in vivo led to the upregulation of AMD-1 not only in mouse lung homogenate but also, most importantly, in pulmonary vessels, the sites of pulmonary vascular remodeling. 3, 29 This is in line with previous findings in which substantial increases in AMD-1 activity in chronic hypoxic rat lungs were noted. 10 Additionally, augmented AMD-1 activity has been described in monocrotaline-treated rats. 30 AMD-1 and lung polyamine contents were found to be elevated in hypoxia. 9, 10 However, no direct molecular in vivo proof for the relevance of its synthesizing enzyme AMD-1 for the development or regression of PH previously existed. To determine the expression and localization of AMD-1, we used quantitative polymerase chain reaction and nonisotopic in situ hybridization instead of conventional protein detection methods such as Western blot analysis and immunohistological stainings because commercially available antibodies demonstrated unspecific stainings. In contrast to the pulmonary vasculature, AMD-1 levels in systemic vessels were almost unaffected by hypoxia. This underscores AMD-1 as a potential target in the pharmacotherapy of PH, which promises fewer side effects than other established treatments. AMD-1 was also upregulated in vessels in patients with human idiopathic pulmonary A, Western blot analysis was performed to determine the phosphorylation of PLC-γ1 after knockdown of AMD-1 in human pulmonary artery smooth muscle cells (n=5) normalized to PLC-γ1. β-Actin served as loading control. B, Protein expression analysis for PLC-γ1 phosphorylation on lung homogenate from AMD-1 +/− mice after exposure to hypoxia for 28 days was normalized to PLC-γ1 (n=4-5 animals each). β-Actin served as loading control. C, PLC-γ1 phosphorylation after 24 hours of endothelial growth factor (EGF) stimulation (50 ng/mL) was assessed in presence or absence of U0126 (10 μmol/L) or the PLC inhibitor U73122 (3 μmol/L; n=4). β-Actin served as loading control. WT indicates wild-type. *P<0.05 vs the indicated group. Figure 8 . The s-adenosylmethionine decarboxylase 1 (AMD-1) inhibitor SAM486a preserved right heart function and pulmonary ventricular resistance and attenuated pulmonary vascular remodeling in chronically hypoxic mice. Wild-type (WT) mice were exposed to either normoxia or 28 days of chronic hypoxia at 10% O 2 and treated with placebo or the AMD-1 inhibitor SAM486a (1 mg/kg body weight [BW] per day IP). A, Right ventricular systolic pressure (RVSP) was assessed by right heart catheterization (n=9-10 each). B, Right heart hypertrophy given as the ratio of right ventricular (RV) to left ventricular (LV) plus septal mass from heart tissue (n=10 each). C, The ratio of pulmonary artery acceleration time/pulmonary artery ejection time (PAAT/PAET), (D) cardiac index (CI), (E) right ventricular internal diameter (RVID), (F) total pulmonary resistance (TPR), and (G) myocardial performance index (MPI) were assessed by echocardiography (n=9-10 animals each). *P<0.05 vs the indicated groups. H, The degree of muscularization of small pulmonary vessels is shown in bar graphs representing mean±SEM. Values are given for nonmuscularized, partially muscularized, or fully muscularized vessels (outer diameter, 20-70 μm) from paraffin-embedded lung sections costained against α-smooth muscle actin (α-sma) and von Willebrand factor (vWF; n=5 animals each). *P<0.05 vs hypoxic placebo control. I, Representative images of lung sections costained against α-sma (violet) and vWF (brown) displaying vessels (V) from indicated mice exposed to normoxia or chronic hypoxia. IgG served as negative control. Scale bars, 20 μm. B indicates bronchus. J, Schematic description of AMD-1 involvement in pulmonary hypertension. Enhanced endothelial growth factor (EGF) levels activate the EGF receptor, which leads to a dimerization and internal phosphorylation. Thus, Erk1/2 phosphorylation and subsequently early growth response-1 (Egr1) expression are augmented, resulting in induced AMD-1 transcription. Consequent enrichment of polyamines induces phospholipase Cγ1 (PLC-γ1) phosphorylation and thus hydrolysis of PIP 2 Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into inositol 1,4,5-trisphosphate (IP 3 ) and diacyl glycerol (DAG). IP 3 induces the release of calcium from the sarcoplasmic reticulum, which increases vascular tone and thus leads to vascular remodeling. 
Weisel et al S-Adenosylmethionine Decarboxylase 1 in PH 1521
arterial hypertension, which emphasizes AMD-1 as a novel target in PH therapy. Because both homozygous AMD-1 −/− and ODC-1 −/− mice exhibit embryonic lethality, 25 ,31 we exposed AMD-1 +/− mice to chronic hypoxia to investigate the role of AMD-1 in vivo. Compared with WT littermates, AMD-1 +/− mice developed less severe hypoxia-induced PH. This can be explained in part by our findings that AMD-1 depletion resulted in decreased proliferation and enhanced apoptosis. The clinical relevance of AMD-1 was further demonstrated by an intervention approach in which application of the inhibitor SAM486a led to improved cardiac function and decreased muscularization of intrapulmonary arteries.
In contrast to AMD-1, ODC-1 did not show changes in mRNA expression in our investigations in mouse lung homogenate. This was mirrored by constant or even decreased expression of ODC-1 in isolated human and mouse PASMCs exposed to hypoxia. Similarly, reduced ODC-1 expression was observed under hypoxic conditions in bovine PASMCs. 32 In our experimental setup, ODC-1 +/− mice did not demonstrate any protective phenotype when exposed to chronic hypoxia. In contrast, in another study, inhibition of ODC-1 in hypoxic rats improved mean pulmonary arterial pressure and medial thickness but did not affect right heart hypertrophy. 11 Although we can speculate that AMD-1 is the key enzyme in polyamine metabolism responsible for hypoxia-induced vascular remodeling and PH, this assumption has to be drawn cautiously because only 1 ODC-1 allele is deleted in ODC-1 +/− mice. Interestingly, in human PASMCs, we could detect increased AMD-1 expression only after 24 hours of exposure to 5% O 2 but at no other investigated condition. Although we cannot exclude that this may have a biologically important effect, we assume that the direct effect of hypoxia on AMD-1 regulation might be rather small. This might be explained by the fact that hypoxia-induced remodeling of the pulmonary circulation is a highly complex process. Multiple interacting events cooperate between various cell types, their differentiation, and the release of mediators such as growth factors. 2, 6, 33 Numerous growth factors being regulated by hypoxia, 34, 35 including platelet-derived growth factor-BB, transforming growth factor-β, and EGF, have been implicated in human PH and animal models of PH. 36 All of them can act as a stimulator of proliferation on different cells on release from, for example, adventitial fibroblasts 33 or endothelial cells. 20 They were also found to modulate AMD-1 levels in various cell types. 37, 38 However, little is known about the regulation of AMD-1 expression in PASMCs. From all the above-mentioned growth factors, we could show that EGF caused the most dramatic increase in AMD-1 expression. This might be of importance because previous studies demonstrated that its concentration can be augmented by hypoxia. 35 Additionally, EGF expression has been elevated in cardiac and pulmonary fibrosis, 39, 40 indicating the involvement in proproliferative diseases. Moreover, blockage of the EGF receptor increased survival and reversed PH in the animal model of monocrotaline-induced PH in rats. 41 Because EGF induces a variety of mediators, including the transcription factor Egr1, 22 which has been reported to be important for cell survival, 42 we have analyzed whether the EGF/Egr1 axis directs AMD-1 expression. In this regard, we proved a direct interaction between Egr1 and the AMD-1 promoter, which was further enhanced by EGF.
To decipher the molecular mechanisms of the EGF/Erk1/2/ Egr1/AMD-1 signaling cascade, we focused on potential downstream targets of AMD-1. Because our microarray analysis revealed phosphatidylinositol signaling to be strongly regulated, we investigated the potential contribution of PLC-γ1 to AMD-1 signaling. PLC-γ1 is a key player of phosphatidylinositol signaling known to increase cytosolic calcium, 43 a process thought to mediate pulmonary vascular remodeling and PH. 44 Indeed, downregulation of AMD-1 in human PASMCs or in mouse lung homogenate resulted in lower PLC-γ1 phosphorylation. Taken together, these findings indicate that AMD-1 might be responsible for the pulmonary remodeling process in response to hypoxia, the subsequent establishment of hypoxia-induced PH, and the regression of PH. This was further emphasized by our pharmacological intervention approach using the AMD-1 inhibitor SAM486a, which resulted in attenuated hypoxia-induced PH. From previous studies, we can speculate that all of our approaches may affect polyamines as 1) polyamines are upregulated during exposure to hypoxia, 9-11 2) pharmacological inhibition of AMD-1 in vivo by 1 mg/kg body weight of SAM486a reduced spermine contents, 45 and 3) prolonged EGF administration in rats was associated with increases in all 3 polyamines, along with augmented mean pulmonary arterial pressure.
46
Conclusions
In this study, we demonstrated altered AMD-1 expression in vascular remodeling and reverse remodeling in hypoxia-induced PH. Furthermore, localization of AMD-1 in the pulmonary vasculature and attenuation of PH in AMD-1 +/− mice strengthened evidence of its key role in PH. In addition, we could identify that upstream signaling of AMD-1 occurs by EGF, Erk1/2, and Egr1, whereas PLC-γ1 phosphorylation might be the downstream driving force for vascular remodeling ( Figure 8J ). Thus, we provided evidence for the first time that pharmacological inhibition of AMD-1 may be a new strategy for the treatment of PH because it resulted in decreased hypoxia-induced PH. 
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CLINICAL PERSPECTIVE
Pulmonary hypertension (PH) is a progressive and life-threatening disease characterized by an increase in pulmonary vascular resistance, which can culminate in cardiac failure and death. Until now, research in the field of PH has concentrated mostly on the onset and development of PH. Therefore, we focused here on the mechanisms underlying the reversal of PH. Although it has previously been shown in rodents that hypoxia-induced vascular remodeling can be reversed by re-exposure to normoxia, the factors involved in this process remain elusive. Using DNA microarray analysis, we screened for such potential factors in reverse remodeling of the pulmonary vasculature on re-exposure of chronically hypoxic animals with PH to normoxia. In addition to other known genes, our whole-genome approach revealed s-adenosylmethionine decarboxylase 1 (AMD-1), one of the major rate-limiting enzymes in polyamine synthesis, as one of the most downregulated genes during this process. The regulation was confirmed by different techniques not only in reverse remodeling but also during the hypoxia-induced remodeling process. Furthermore, attenuation of hypoxia-induced PH in wild-type mice treated with the AMD-1 inhibitor SAM486a (1 mg/kg body weight IP) and AMD-1 +/− mice strengthened evidence of its key role in PH. Thus, pharmacological inhibition of AMD-1 may be a new strategy for the treatment of PH if these results are transferable to humans. For monitoring hemodynamics in the knockout mice and the wild-type mice during reverse remodeling, the animals were anesthetized interperitoneally with ketamine (40µg/g body weight) and Rompun 2% (0,6µg/g body weight). Measurement of right ventricular systemic pressure (RVSP) and systemic arterial pressure (SAP) was performed as described previously 1 . Briefly, the left carotid artery was cannulated, and a right heart catheter was inserted through the right jugular vein for measurement of RVSP with fluid filled pressure transducers. After exsanguination, the left lung was fixed for histology in 10% neutral buffered formalin, and the right lung was snap-frozen in liquid nitrogen. For right heart hypertrophy, the right ventricle (RV) was separated from the left ventricle plus septum (LV+S) and the RV/(LV+S) ratio was determined from the tissue. Hemodynamics in mice treated with SAM486a or placebo were measured as described previously 2 with slight modifications. Briefly, anesthesia was induced with isoflurane gas (3%) after pretreatment with buprenorphine (0.05mg/kg, sc) and maintained with 1.5% isoflurane in room air supplemented with 100% O 2 . After intubation the mouse was placed supine on a homeothermic plate (AD Instruments, Spechbach, Germany) and connected to a small animal ventilator MiniVent type 845 (Hugo Sachs Elektronik, March-Hugstetten, Germany). The body temperature was controlled by the rectal probe connected to the control unit (AD Instruments, Spechbach, Germany) and was kept at 37°C during the catheterization. The right external jugular vein was catheterized with a high fidelity 1.4F micromanometer catheter (Millar Instruments, Houston, USA) and advanced into the right ventricle to assess RVSP.
Subsequently, the high fidelity 1.4F micromanometer catheter was inserted into the aorta and the left ventricle through the right carotid artery for measurement of SAP. Data was collected and analyzed using the PowerLab data acquisition system (MPVS-Ultra Single Segment Foundation System, AD Instruments, Spechbach, Germany) and LabChart 7 for Windows software.
Echocardiography was assessed as previously described 3, 4 . Briefly, anesthesia was induced with isoflurane gas (3%) and maintained with 1.5% isoflurane in room air supplemented with 100% O 2 . Mice were laid in supine position on a heating platform with all legs taped to ECG electrodes for heart rate (HR) monitoring. Body temperature was monitored via a rectal thermometer (Indus Instruments, Houston, TX). The chest of the mice was shaved. To provide a coupling medium for the transducer, a pre-warmed ultrasound gel was spread over the chest wall. Transthoracic echocardiography was performed with Vevo770 high-resolution imaging system equipped by 30-MHz transducer (VisualSonics, Toronto, Canada). Cardiac output (CO) was calculated as the product of the velocity-time integral of the pulsed-Doppler tracing in the LV outflow tract, the cross-sectional area of the LV outflow tract, and the HR.
CI was derived by dividing CO by body weight. The right ventricular internal diameter (RVID), pulmonary artery acceleration time (PAAT) and myocardial performance index (MPI) were measured. Additionally, total pulmonary resistance (TPR) was calculated 5 .
Paraffin embedding and microscopy
For vascular morphometry, lungs were fixed by vascular perfusion with Zamboni's fixative through the pulmonary artery after flushing the lungs with saline at a vascular pressure of 22 cm H 2 O and a tracheal pressure of 12 cm H 2 O. Investigations were performed from 3 µm sections of paraffin embedded lungs. The degree of muscularization was determined from lung sections stained using antibodies against α-smooth muscle actin (α-sma) and von
Willebrand factor (vWF) as described previously 1, 6 . An antibody directed against IgG (Millipore, Schwalbach, Germany) served as negative control.
Lungs were fixed by immersion in a 3.5% paraformaldehyde solution. For paraffin embedding, the lungs were dissected in tissue blocks. The degree of muscularization of pulmonary arterial vessels was determined as described 7, 8 
PCNA staining
For immunohistochemical localization of PCNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA), the AP-fast red kit (Zytochem, Berlin, Germany) was used on paraffin-embedded lung sections according to the manufacturer's instructions. All stained sections were analyzed using digital slide scanning employing a mirax scanner and the mirax viewer software (Carl Zeiss GmbH, Jena, Germany). An antibody directed against IgG (Millipore, Schwalbach, Germany) served as negative control.
Laser-microdissection, RNA isolation, cDNA synthesis and q-PCR
Laser-assisted microdissection was performed to isolate pulmonary arterial vessels from cryostat lung sections as previously described 9 . Total messenger RNA was extracted from frozen mouse or human lung tissue and microdissected vessels by using the RNeasy Mini or 
Microarray
RNA from 80 animals (20 controls and 12 per time point) were analyzed in a total of 40 dualcolor hybridizations in a balanced dye-swap design where each time point was directly compared to the control and to the adjacent time points. Table 1 shows which combinations were hybridized in detail.
RNA was purified using the RNeasy Mini Kit (QIAgen, Hilden, Germany) following the kit's instructions. RNA quality was assessed by capillary electrophoresis using the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA).
Purified total RNA was amplified and Cy-labeled using the dual-color QuickAmp kit (Agilent 
Microarray data analysis
Stored data were evaluated using the R software 10 and the limma package 11 from BioConductor 12 . Data from technical replicates (hypoxia dye-swap data) were averaged. Data from replicate spots were averaged prior to further analysis. The M/A data were LOESS normalized 13 before averaging using the "lmFit" function. Genes were ranked for differential expression using a moderated t-statistic 14 . Candidate lists were created by adjusting the falsediscovery rate to 5%. Geneset enrichment analyses were done using the "geneSetTest" function together with the KEGG pathway information given in the Bioconductor database package mgug4122a.db version 2.2.5. Significantly enriched pathways were selected on the basis of a 5% false-discovery rate.
Isolation of aorta and carotid artery
After exposure to either normoxia or hypoxia for 1, 7 or 21 days, mice were anesthetized interperitoneally with ketamine and xylazine. Subsequently, the A. carotis interna and externa including the bifurcation were isolated. The aorta was separated from the heart close to the aortic arch and disconnected from the adventitia. Afterwards, the carotid arteries and the aortas were washed in sterile, ice-cold PBS and snap-frozen in liquid nitrogen.
Non-isotopic in situ hybridization (NISH) combined with immunofluorescence on mouse lung sections
Non-isotopic in situ hybridization on mouse lungs was carried out as previously described 
Proliferation assay
HPASMCs were seeded on 6-well plates and transfected with control siRNA (siR) or siRNA against AMD-1 when grown to near confluence. 72h after transfection, cells were trypsinized and counted in a Neubauer counting chamber (LO -Laboroptik GmbH, Bad Homburg, Germany). Values were normalized to siR.
Apoptosis Assay
hPASMCs were grown to near confluence and transfected against siR or siAMD-1, respectively. Apoptosis rate was analysed 72h after transfection using the CaspACE™ Assay System, Colorimetric Kit (Promega, Mannheim, Germany) according to manufacturer's instructions. Staurosporine (1µm, Sigma-Aldrich, Munich, Germany) was incubated for four hours and served as positive control.
Plasmid Construction
Full-length human AMD-1 cDNA (accession number NM_001634) was amplified from a Supplemental Tables   Table 1) Hybridizations in the reverse remodeling experiment. The numbers denote time points (in days), zero indicates the controls. Each combination was hybridized twice, using RNA from different animals. experiments, compared to normoxic controls and normalized to B2M. * p<0.05 compared to respective controls.
Supplemental figure 7)
The AMD-1 promoter possesses one potential Egr1 binding site A) Bioinformatic analysis of the human AMD-1 promoter revealed one potential binding site for Egr1.
